GO Term |
---|
negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO Term |
---|
focal adhesion |
cell surface |
macrophage migration inhibitory factor receptor complex |
Golgi apparatus |
plasma membrane |
microvillus |
secretory granule membrane |
cell projection |
extracellular exosome |
basolateral plasma membrane |
GO Term |
---|
transmembrane signaling receptor activity |
cytokine receptor activity |
collagen binding |
hyaluronic acid binding |
Position | Description | PubMed ID | GlyTouCan ID | Source |
---|---|---|---|---|
25 | N-linked (GlcNAc...) asparagine | |||
57 | N-linked (GlcNAc...) asparagine |
|
||
100 | N-linked (GlcNAc...) asparagine |
|
||
110 | N-linked (GlcNAc...) asparagine |
|
||
120 | N-linked (GlcNAc...) asparagine |
|
||
162 |
|
|||
163 |
|
|||
174 |
|
|||
180 | O-linked (Xyl...) (chondroitin sulfate) serine |
|
||
197 |
|
Pathway Name | Organism |
---|---|
Cell surface interactions at the vascular wall | Homo sapiens |
Degradation of the extracellular matrix | Homo sapiens |
Hyaluronan uptake and degradation | Homo sapiens |
Integrin cell surface interactions | Homo sapiens |
Interferon gamma signaling | Homo sapiens |
Neutrophil degranulation | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:0110159 | Charcot-Marie-Tooth disease type 2B | |
DOID:0110160 | Charcot-Marie-Tooth disease axonal type 2T | |
DOID:0110161 | Charcot-Marie-Tooth disease type 2R | |
DOID:0110163 | Charcot-Marie-Tooth disease axonal type 2F | |
DOID:0110164 | Charcot-Marie-Tooth disease type 2D | |
DOID:0110165 | Charcot-Marie-Tooth disease type 2E | |
DOID:0110166 | Charcot-Marie-Tooth disease axonal type 2H | |
DOID:0110167 | Charcot-Marie-Tooth disease axonal type 2K | |
DOID:0110168 | Charcot-Marie-Tooth disease type 2Y | |
DOID:0110169 | Charcot-Marie-Tooth disease axonal type 2P |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024